|
1
|
Lowenstein PR and Castro MG: Evolutionary
basis of a new gene- and immune-therapeutic approach for the
treatment of malignant brain tumors: From mice to clinical trials
for glioma patients. Clin Immunol. 189:43–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baker GJ, Yadav VN, Motsch S, Koschmann C,
Calinescu AA, Mineharu Y, Camelo-Piragua SI, Orringer D, Bannykh S,
Nichols WS, et al: Mechanisms of glioma formation: Iterative
perivascular glioma growth and invasion leads to tumor progression,
VEGF-independent vascularization, and resistance to antiangiogenic
therapy. Neoplasia. 16:543–561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakano I and Kornblum HI: Methods for
analysis of brain tumor stem cell and neural stem cell
self-renewal. Methods Mol Biol. 568:37–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Turner JD and Sanai N: A brain tumor stem
cell origin for glioblastoma endothelium. World Neurosurg.
75:574–575. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khan IS and Ehtesham M: Isolation and
characterization of stem cells from human central nervous system
malignancies. Adv Exp Med Biol. 853:33–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bryukhovetskiy A, Shevchenko V, Kovalev S,
Chekhonin V, Baklaushev V, Bryukhovetskiy I and Zhukova M: To the
novel paradigm of proteome-based cell therapy of tumors: Through
comparative proteome mapping of tumor stem cells and
tissue-specific stem cells of humans. Cell Transplant. 23 Suppl
1:S151–S170. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toda M: Identification of antigen against
brain tumor stem cell and application for treatment of glioma. Gan
To Kagaku Ryoho. 37:1016–1018. 2010.(In Japanese). PubMed/NCBI
|
|
8
|
Tanaka S, Louis DN, Curry WT, Batchelor TT
and Dietrich J: Diagnostic and therapeutic avenues for
glioblastoma: No longer a dead end? Nat Rev Clin Oncol. 10:14–26.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lathia JD, Li M, Hall PE, Gallagher J,
Hale JS, Wu Q, Venere M, Levy E, Rani MR, Huang P, et al: Laminin
alpha 2 enables glioblastoma stem cell growth. Ann Neurol.
72:766–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sherriff J, Tamangani J, Senthil L,
Cruickshank G, Spooner D, Jones B, Brookes C and Sanghera P:
Patterns of relapse in glioblastoma multiforme following
concomitant chemoradiotherapy with temozolomide. Br J Radiol.
86:201204142013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Neradil J and Veselska R: Nestin as a
marker of cancer stem cells. Cancer Sci. 106:803–811. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tampaki EC, Nakopoulou L, Tampakis A,
Kontzoglou K, Weber WP and Kouraklis G: Nestin involvement in
tissue injury and cancer-a potential tumor marker? Cell Oncol
(Dordr). 37:305–315. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yiming L, Yunshan G, Bo M, Yu Z, Tao W,
Gengfang L, Dexian F, Shiqian C, Jianli J, Juan T and Zhinan C:
CD133 overexpression correlates with clinicopathological features
of gastric cancer patients and its impact on survival: A systematic
review and meta-analysis. Oncotarget. 6:42019–42027. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kemper K, Grandela C and Medema JP:
Molecular identification and targeting of colorectal cancer stem
cells. Oncotarget. 1:387–395. 2010.PubMed/NCBI
|
|
15
|
Garcia A and Kandel JJ: Notch: A key
regulator of tumor angiogenesis and metastasis. Histol Histopathol.
27:151–156. 2012.PubMed/NCBI
|
|
16
|
Ye L, Wang C, Yu G, Jiang Y, Sun D, Zhang
Z, Yu X, Li X, Wei W, Liu P, et al: Bmi-1 induces radioresistance
by suppressing senescence in human U87 glioma cells. Oncol Lett.
8:2601–2606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wilson NH and Stoeckli ET: Sonic Hedgehog
regulates Wnt activity during neural circuit formation. Vitam Horm.
88:173–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Foldynová-Trantírková S, Sekyrová P,
Tmejová K, Brumovská E, Bernatík O, Blankenfeldt W, Krejcí P,
Kozubík A, Dolezal T, Trantírek L and Bryja V: Breast
cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin
and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell
adhesion and promote cell migration. Breast Cancer Res. 12:R302010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Izraeli S, Lowe LA, Bertness VL, Campaner
S, Hahn H, Kirsch IR and Kuehn MR: Genetic evidence that Sil is
required for the Sonic Hedgehog response pathway. Genesis.
31:72–77. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin X, Jeon HM, Jin X, Kim EJ, Yin J, Jeon
HY, Sohn YW, Oh SY, Kim JK, Kim SH, et al: The ID1-CULLIN3 axis
regulates intracellular SHH and WNT signaling in glioblastoma stem
cells. Cell Rep. 16:1629–1641. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Filbin MG, Dabral SK, Pazyra-Murphy MF,
Ramkissoon S, Kung AL, Pak E, Chung J, Theisen MA, Sun Y,
Franchetti Y, et al: Coordinate activation of Shh and PI3K
signaling in PTEN-deficient glioblastoma: New therapeutic
opportunities. Nat Med. 19:1518–1523. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou QZ, Zhang G, Long HB, Lei F, Ye F,
Jia XF, Zhou YL, Kang JP and Feng DX: Effect of spinal cord
extracts after spinal cord injury on proliferation of rat embryonic
neural stem cells and Notch signal pathway in vitro. Asian Pac J
Trop Med. 7:562–567. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen CY, Liao W, Lou YL, Li Q, Hu B, Wang
Y and Deng ZF: Inhibition of Notch signaling facilitates the
differentiation of human-induced pluripotent stem cells into neural
stem cells. Mol Cell Biochem. 395:291–298. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saito N, Fu J, Zheng S, Yao J, Wang S, Liu
DD, Yuan Y, Sulman EP, Lang FF, Colman H, et al: A high Notch
pathway activation predicts response to γ secretase inhibitors in
proneural subtype of glioma tumor-initiating cells. Stem Cells.
32:301–312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Glass R and Synowitz M: CNS macrophages
and peripheral myeloid cells in brain tumours. Acta Neuropathol.
128:347–362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu M, Xiang FX and He YF: Are cancer stem
cells the sole source of tumor? J Huazhong Univ Sci Technolog Med
Sci. 34:621–625. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alamgeer M, Peacock CD, Matsui W, Ganju V
and Watkins DN: Cancer stem cells in lung cancer: Evidence and
controversies. Respirology. 18:757–764. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fong D, Yeh A, Naftalovich R, Choi TH and
Chan MM: Curcumin inhibits the side population (SP) phenotype of
the rat C6 glioma cell line: Towards targeting of cancer stem cells
with phytochemicals. Cancer Lett. 293:65–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lucarelli G, Galleggiante V, Rutigliano M,
Vavallo A, Ditonno P and Battaglia M: Isolation and
characterization of cancer stem cells in renal cell carcinoma.
Urologia. 82:46–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lehnus KS, Donovan LK, Huang X, Zhao N,
Warr TJ, Pilkington GJ and An Q: CD133 glycosylation is enhanced by
hypoxia in cultured glioma stem cells. Int J Oncol. 42:1011–1017.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brazel CY, Alaythan AA, Felling RJ,
Calderon F and Levison SW: Molecular features of neural stem cells
enable their enrichment using pharmacological inhibitors of
survival-promoting kinases. J Neurochem. 128:376–390. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tamura K, Aoyagi M, Ando N, Ogishima T,
Wakimoto H, Yamamoto M and Ohno K: Expansion of CD133-positive
glioma cells in recurrent de novo glioblastomas after radiotherapy
and chemotherapy. J Neurosurg. 119:1145–1155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fang KM, Lin TC, Chan TC, Ma SZ, Tzou BC,
Chang WR, Liu JJ, Chiou SH, Yang CS and Tzeng SF: Enhanced cell
growth and tumorigenicity of rat glioma cells by stable expression
of human CD133 through multiple molecular actions. Glia.
61:1402–1417. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim SH and Singh SV: Mammary cancer
chemoprevention by withaferin A is accompanied by in vivo
suppression of self-renewal of cancer stem cells. Cancer Prev Res
(Phila). 7:738–747. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Chen T, Zhang J, Mao Q, Li S,
Xiong W, Qiu Y, Xie Q and Ge J: Notch1 promotes glioma cell
migration and invasion by stimulating β-catenin and NF-κB signaling
via AKT activation. Cancer Sci. 103:181–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiao YG, Wang W, Gong D and Mao ZF:
γ-Secretase inhibitor DAPT attenuates intimal hyperplasia of vein
grafts by inhibition of Notch1 signaling. Lab Invest. 94:654–662.
2014. View Article : Google Scholar : PubMed/NCBI
|
